Discerning computational, in vitro and in vivo investigations of self-assembling empagliflozin polymeric micelles in type-2 diabetes
Drug Delivery and Translational Research · 2024
DOI: 10.1007/s13346-024-01658-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2024. Verfasst von Priti Wagh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Maliba Pharmacy College, Uka Tarsadia University, Bardoli-Mahuva Road,At & Po, Tarsadi, Bardoli, Gujarat, 394350, India. Hauptthemen laut MEDLINE: Glucosides, Micelles, Benzhydryl Compounds, Molecular Docking Simulation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Empagliflozin (EMPA) is an SGLT2 inhibitor, a new class of anti-diabetic medication, indicated for treating type-2 diabetes. Its low permeability, poor solubility and bioavailability limits its use in management of diabetes. The study was aimed to formulate EMPA loaded polymeric micelles (PMs) to overcome these obstacles in oral absorption. METHODOLOGY: In silico studies-molecular docking, molecular dynamic simulation (MDS), and quantum chemical calculation were employed to study the interaction of EMPA with different polymers. EMPA loaded TPGS polymeric micelles (EMPA-TPGS-PMs) were formulated by direct dissolution method and characterized in terms of surface morphology, entrapment, particle size, in vitro drug release, and in vitro cytotoxicity (HEK293 cells). In vivo pharmacokinetic and pharmacodynamic studies were also performed. RESULTS: The results suggested a good interaction between TPGS and EMPA with lowest binding energy compared to other polymers. Further MDS results and DFT calculations validated the stable binding of the complex hence TPGS was selected for further wet lab experiments. The EMPA-TPGS complex displayed lower value of Total energy (T.E.) than its individual components, indicating the overall stability of the complex while, the energy band gap (∆E) value lied between the two individual molecules, signifying the better electron transfer between HOMO and LUMO of the complex. Based on the solubility, entrapment and cytotoxicity studies, 5% TPGS was selected for formulating drug loaded micelles. EMPA-TPGS5-PMs presented a size of 9.008 ± 1.25 nm, Polydispersity index (PDI) of 0.254 ± 0.100, a controlled release behaviour upto 24 h. SEM and AFM images of the nanoformulation suggested spherical particles whereas, DSC, and PXRD studies confirmed the loss of crystallinity of EMPA. A 3.12-folds higher AUC and a greater reduction in blood glucose levels was exhibited by EMPA-TPGS5-PMs in comparison to EMPA-SUSP in mice model. CONCLUSION: EMPA-TPGS-PMs has exhibited better bio absorption and therapeutic effectiveness in diabetes treatment. This improved performance would open the possibility of dose reduction, reduced dosing frequency & dose-related side effects, improving pharmaco-economics and thereby improved overall compliance to the patient. However, this translation from bench to bedside would necessitate studies in higher animals and human volunteers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Maliba Pharmacy College, Uka Tarsadia University, Bardoli-Mahuva Road,At & Po, Tarsadi, Bardoli, Gujarat, 394350, India.
- C.G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Tarsadi, Bardoli, Gujarat, 394350, India.
- Department of Pharmacology, Maliba Pharmacy College, Uka Tarsadia University, Tarsadi, Bardoli, Gujarat, 394350, India.
- Department of Chemistry, Sardar Vallabhbhai National Institute of Technology (SVNIT), Surat, Gujarat, 395007, India.
- Parul Institute of Pharmacy and Research, Parul University, Waghodia, Vadodara, Gujarat, 391760, India.
- Department of Pharmaceutics, Maliba Pharmacy College, Uka Tarsadia University, Bardoli-Mahuva Road,At & Po, Tarsadi, Bardoli, Gujarat, 394350, India. pranav.shah@utu.ac.in.
ORCID-Profile: Pranav Shah
Zitieren
APA
Wagh, P., Savaliya, S., Joshi, B., Vyas, B., Kuperkar, K., Lalan, M., & Shah, P. (2024). Discerning computational, in vitro and in vivo investigations of self-assembling empagliflozin polymeric micelles in type-2 diabetes. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01658-y
Vancouver
Wagh P, Savaliya S, Joshi B, Vyas B, Kuperkar K, Lalan M, et al. Discerning computational, in vitro and in vivo investigations of self-assembling empagliflozin polymeric micelles in type-2 diabetes. Drug Delivery and Translational Research. 2024. doi:10.1007/s13346-024-01658-y
BibTeX
@article{Wagh2024,
author = {Wagh, Priti and Savaliya, Shivani and Joshi, Bhrugesh and Vyas, Bhavin and Kuperkar, Ketan and Lalan, Manisha and Shah, Pranav},
title = {Discerning computational, in vitro and in vivo investigations of self-assembling empagliflozin polymeric micelles in type-2 diabetes},
journal = {Drug Delivery and Translational Research},
year = {2024},
doi = {10.1007/s13346-024-01658-y}
}
EUVIMED